These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 12577304)

  • 1. A unified model for the action of leptin on bone turnover.
    Gordeladze JO; Reseland JE
    J Cell Biochem; 2003 Mar; 88(4):706-12. PubMed ID: 12577304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leptin effect on RANKL and OPG expression in MC3T3-E1 osteoblasts.
    Lamghari M; Tavares L; Camboa N; Barbosa MA
    J Cell Biochem; 2006 Aug; 98(5):1123-9. PubMed ID: 16479591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor necrosis factor-alpha cooperates with receptor activator of nuclear factor kappaB ligand in generation of osteoclasts in stromal cell-depleted rat bone marrow cell culture.
    Komine M; Kukita A; Kukita T; Ogata Y; Hotokebuchi T; Kohashi O
    Bone; 2001 May; 28(5):474-83. PubMed ID: 11344046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Recent advances in the regulation of bone remodeling].
    Matsumoto T
    Nihon Rinsho; 2004 Feb; 62 Suppl 2():37-46. PubMed ID: 15035093
    [No Abstract]   [Full Text] [Related]  

  • 5. Human trabecular bone-derived osteoblasts support human osteoclast formation in vitro in a defined, serum-free medium.
    Atkins GJ; Kostakis P; Welldon KJ; Vincent C; Findlay DM; Zannettino AC
    J Cell Physiol; 2005 Jun; 203(3):573-82. PubMed ID: 15573398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leptin inhibits osteoclast generation.
    Holloway WR; Collier FM; Aitken CJ; Myers DE; Hodge JM; Malakellis M; Gough TJ; Collier GR; Nicholson GC
    J Bone Miner Res; 2002 Feb; 17(2):200-9. PubMed ID: 11811550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted overexpression of G protein-coupled receptor kinase-2 in osteoblasts promotes bone loss.
    Wang L; Liu S; Quarles LD; Spurney RF
    Am J Physiol Endocrinol Metab; 2005 Apr; 288(4):E826-34. PubMed ID: 15585587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leptin stimulates human osteoblastic cell proliferation, de novo collagen synthesis, and mineralization: Impact on differentiation markers, apoptosis, and osteoclastic signaling.
    Gordeladze JO; Drevon CA; Syversen U; Reseland JE
    J Cell Biochem; 2002; 85(4):825-36. PubMed ID: 11968022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aging increases stromal/osteoblastic cell-induced osteoclastogenesis and alters the osteoclast precursor pool in the mouse.
    Cao JJ; Wronski TJ; Iwaniec U; Phleger L; Kurimoto P; Boudignon B; Halloran BP
    J Bone Miner Res; 2005 Sep; 20(9):1659-68. PubMed ID: 16059637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of osteoclast differentiation by fibroblast growth factor 2: stimulation of receptor activator of nuclear factor kappaB ligand/osteoclast differentiation factor expression in osteoblasts and inhibition of macrophage colony-stimulating factor function in osteoclast precursors.
    Chikazu D; Katagiri M; Ogasawara T; Ogata N; Shimoaka T; Takato T; Nakamura K; Kawaguchi H
    J Bone Miner Res; 2001 Nov; 16(11):2074-81. PubMed ID: 11697804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Recent advances in basic research of bone metabolism].
    Inoue D; Matsumoto T
    Nihon Rinsho; 2002 Mar; 60 Suppl 3():25-33. PubMed ID: 11979916
    [No Abstract]   [Full Text] [Related]  

  • 12. Isopropanolic extract of black cohosh stimulates osteoprotegerin production by human osteoblasts.
    Viereck V; Gründker C; Friess SC; Frosch KH; Raddatz D; Schoppet M; Nisslein T; Emons G; Hofbauer LC
    J Bone Miner Res; 2005 Nov; 20(11):2036-43. PubMed ID: 16234977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relevance of an in vitro osteoclastogenesis system to study receptor activator of NF-kB ligand and osteoprotegerin biological activities.
    Wittrant Y; Theoleyre S; Couillaud S; Dunstan C; Heymann D; Rédini F
    Exp Cell Res; 2004 Feb; 293(2):292-301. PubMed ID: 14729467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of hormone and cytokine-stimulated osteoclastogenesis and bone resorption by interleukin-4 and interleukin-13 is associated with increased osteoprotegerin and decreased RANKL and RANK in a STAT6-dependent pathway.
    Palmqvist P; Lundberg P; Persson E; Johansson A; Lundgren I; Lie A; Conaway HH; Lerner UH
    J Biol Chem; 2006 Feb; 281(5):2414-29. PubMed ID: 16251181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human osteoblast precursors produce extracellular adenosine, which modulates their secretion of IL-6 and osteoprotegerin.
    Evans BA; Elford C; Pexa A; Francis K; Hughes AC; Deussen A; Ham J
    J Bone Miner Res; 2006 Feb; 21(2):228-36. PubMed ID: 16418778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating osteoprotegerin and leptin levels in postmenopausal women with and without osteoporosis.
    Grigorie D; Neacşu E; Marinescu M; Popa O
    Rom J Intern Med; 2003; 41(4):409-15. PubMed ID: 15526523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The cytokine system of bone tissue].
    Stilgren LS; Abrahamsen B; Abdallah BM; Jørgensen NR
    Ugeskr Laeger; 2005 Feb; 167(8):874-8. PubMed ID: 15789838
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of different magnitudes of mechanical strain on Osteoblasts in vitro.
    Tang L; Lin Z; Li YM
    Biochem Biophys Res Commun; 2006 May; 344(1):122-8. PubMed ID: 16603128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct actions of leptin on bone remodeling.
    Reid IR; Comish J
    Calcif Tissue Int; 2004 Apr; 74(4):313-6. PubMed ID: 15255066
    [No Abstract]   [Full Text] [Related]  

  • 20. [Role of receptor activator of nuclear factor kappa B (RANK), its ligand (RANK-L) and osteoprotegerin (OPG) in bone metabolism].
    Stajszczyk M
    Pol Arch Med Wewn; 2002 Sep; 108(3):915-24. PubMed ID: 12600190
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.